| Andrew S Khan, DO | |
|
15248 11th St, Emergency Department, Victorville, CA 92395-3704 | |
| (760) 245-8691 | |
| (760) 843-6020 |
| Full Name | Andrew S Khan |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 15248 11th St, Victorville, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750330932 | NPI | - | NPPES |
| 00AX65010 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 20A6501 (California) | Primary |
| Entity Name | Oakdale Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598862054 PECOS PAC ID: 4587567490 Enrollment ID: O20040216000564 |
News Archive
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers.
Micrus Endovascular Corporation and privately held Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the signing of an exclusive agreement to jointly develop a flow diversion technology for neurovascular indications using both Micrus and Flexible Stenting Solutions technology, development capabilities and intellectual property.
A new study by Israeli researchers tested the hypothesis that certain SARS-CoV-2 variants of concern can overcome protection conferred by Pfizer-BioNTech (BNT162b2) mRNA vaccine and found evidence of increased breakthrough rates in vaccinated individuals. The research paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
| Entity Name | Altamont Emergency Physicians Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952392375 PECOS PAC ID: 5496700759 Enrollment ID: O20050318000840 |
News Archive
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers.
Micrus Endovascular Corporation and privately held Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the signing of an exclusive agreement to jointly develop a flow diversion technology for neurovascular indications using both Micrus and Flexible Stenting Solutions technology, development capabilities and intellectual property.
A new study by Israeli researchers tested the hypothesis that certain SARS-CoV-2 variants of concern can overcome protection conferred by Pfizer-BioNTech (BNT162b2) mRNA vaccine and found evidence of increased breakthrough rates in vaccinated individuals. The research paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
| Entity Name | Beach Emergency Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013074996 PECOS PAC ID: 8123120078 Enrollment ID: O20070222000661 |
News Archive
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers.
Micrus Endovascular Corporation and privately held Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the signing of an exclusive agreement to jointly develop a flow diversion technology for neurovascular indications using both Micrus and Flexible Stenting Solutions technology, development capabilities and intellectual property.
A new study by Israeli researchers tested the hypothesis that certain SARS-CoV-2 variants of concern can overcome protection conferred by Pfizer-BioNTech (BNT162b2) mRNA vaccine and found evidence of increased breakthrough rates in vaccinated individuals. The research paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
| Entity Name | Pacific Coast Emergency Medical Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316179492 PECOS PAC ID: 5092861054 Enrollment ID: O20090917000115 |
News Archive
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers.
Micrus Endovascular Corporation and privately held Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the signing of an exclusive agreement to jointly develop a flow diversion technology for neurovascular indications using both Micrus and Flexible Stenting Solutions technology, development capabilities and intellectual property.
A new study by Israeli researchers tested the hypothesis that certain SARS-CoV-2 variants of concern can overcome protection conferred by Pfizer-BioNTech (BNT162b2) mRNA vaccine and found evidence of increased breakthrough rates in vaccinated individuals. The research paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
| Entity Name | San Joaquin Emergency Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588960413 PECOS PAC ID: 6305022047 Enrollment ID: O20110516000103 |
News Archive
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers.
Micrus Endovascular Corporation and privately held Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the signing of an exclusive agreement to jointly develop a flow diversion technology for neurovascular indications using both Micrus and Flexible Stenting Solutions technology, development capabilities and intellectual property.
A new study by Israeli researchers tested the hypothesis that certain SARS-CoV-2 variants of concern can overcome protection conferred by Pfizer-BioNTech (BNT162b2) mRNA vaccine and found evidence of increased breakthrough rates in vaccinated individuals. The research paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
| Entity Name | Apex Emergency Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265711089 PECOS PAC ID: 4688844277 Enrollment ID: O20110909002790 |
News Archive
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers.
Micrus Endovascular Corporation and privately held Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the signing of an exclusive agreement to jointly develop a flow diversion technology for neurovascular indications using both Micrus and Flexible Stenting Solutions technology, development capabilities and intellectual property.
A new study by Israeli researchers tested the hypothesis that certain SARS-CoV-2 variants of concern can overcome protection conferred by Pfizer-BioNTech (BNT162b2) mRNA vaccine and found evidence of increased breakthrough rates in vaccinated individuals. The research paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
| Entity Name | Mount Eddy Emergency Physicians Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Other |
| Entity Identifiers | NPI Number: 1316299787 PECOS PAC ID: 7416100714 Enrollment ID: O20130118000029 |
News Archive
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers.
Micrus Endovascular Corporation and privately held Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the signing of an exclusive agreement to jointly develop a flow diversion technology for neurovascular indications using both Micrus and Flexible Stenting Solutions technology, development capabilities and intellectual property.
A new study by Israeli researchers tested the hypothesis that certain SARS-CoV-2 variants of concern can overcome protection conferred by Pfizer-BioNTech (BNT162b2) mRNA vaccine and found evidence of increased breakthrough rates in vaccinated individuals. The research paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
| Entity Name | Grand Avenue Emergency Physicians Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962913632 PECOS PAC ID: 7315206653 Enrollment ID: O20180112002313 |
News Archive
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers.
Micrus Endovascular Corporation and privately held Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the signing of an exclusive agreement to jointly develop a flow diversion technology for neurovascular indications using both Micrus and Flexible Stenting Solutions technology, development capabilities and intellectual property.
A new study by Israeli researchers tested the hypothesis that certain SARS-CoV-2 variants of concern can overcome protection conferred by Pfizer-BioNTech (BNT162b2) mRNA vaccine and found evidence of increased breakthrough rates in vaccinated individuals. The research paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
| Entity Name | Apex Emergency Medical Group- Chapman Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659912798 PECOS PAC ID: 0840626354 Enrollment ID: O20200131001456 |
News Archive
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers.
Micrus Endovascular Corporation and privately held Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the signing of an exclusive agreement to jointly develop a flow diversion technology for neurovascular indications using both Micrus and Flexible Stenting Solutions technology, development capabilities and intellectual property.
A new study by Israeli researchers tested the hypothesis that certain SARS-CoV-2 variants of concern can overcome protection conferred by Pfizer-BioNTech (BNT162b2) mRNA vaccine and found evidence of increased breakthrough rates in vaccinated individuals. The research paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
| Entity Name | Seven Star Hospital Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043813140 PECOS PAC ID: 4789083338 Enrollment ID: O20210601002852 |
News Archive
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers.
Micrus Endovascular Corporation and privately held Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the signing of an exclusive agreement to jointly develop a flow diversion technology for neurovascular indications using both Micrus and Flexible Stenting Solutions technology, development capabilities and intellectual property.
A new study by Israeli researchers tested the hypothesis that certain SARS-CoV-2 variants of concern can overcome protection conferred by Pfizer-BioNTech (BNT162b2) mRNA vaccine and found evidence of increased breakthrough rates in vaccinated individuals. The research paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew S Khan, DO Po Box 660519, Arcadia, CA 91066-0519 Ph: (626) 447-0296 | Andrew S Khan, DO 15248 11th St, Emergency Department, Victorville, CA 92395-3704 Ph: (760) 245-8691 |
News Archive
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers.
Micrus Endovascular Corporation and privately held Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the signing of an exclusive agreement to jointly develop a flow diversion technology for neurovascular indications using both Micrus and Flexible Stenting Solutions technology, development capabilities and intellectual property.
A new study by Israeli researchers tested the hypothesis that certain SARS-CoV-2 variants of concern can overcome protection conferred by Pfizer-BioNTech (BNT162b2) mRNA vaccine and found evidence of increased breakthrough rates in vaccinated individuals. The research paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
Melvin Webb, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 15248 11th St, Emergency Department, Victorville, CA 92395 Phone: 760-245-8691 Fax: 760-843-6020 | |
Alexander Cruise, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 16850 Bear Valley Rd, Victorville, CA 92395 Phone: 760-241-8000 | |
John Stroh, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15248 11th St, Emergency Department, Victorville, CA 92395 Phone: 760-245-8691 Fax: 760-843-6020 | |
Mark M. Youssef, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 15248 11th St, Emergency Department, Victorville, CA 92395 Phone: 760-245-8691 Fax: 760-843-6020 | |
Paulo Reyes, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15248 11th St, Emergency Department, Victorville, CA 92395 Phone: 760-245-8691 Fax: 760-843-6020 | |
Raafat Wassef, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 16850 Bear Valley Rd, Victorville, CA 92395 Phone: 760-241-8000 | |
Dr. Leroy B. Pascal, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 15248 11th St, Emergency Department, Victorville, CA 92395 Phone: 760-245-8691 Fax: 760-843-6020 |